| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Pvu9g1660 | ATGGAGGGTGTTGTGAGCCCTGAAGAACCATCACAGAGGTCACCGTTGGATTCCAGTTCCAAACAAGACACAACCAATGAAGTATTGAAAGACAGCACTGATGCCGAAATCACCAAGATTCGTCTCATGAGGGCCTTTGTTGAAGCCCGAGATCCCTCTTCCAAGGAAGTGGATGATTTGATGATTAGAAGATTCTTGCGGGCTCGTAATTTAGATGTGGAGAAGGGTTCGGCGATGTTCCTGAAGTACTTGAATTGGAAACGTTCGATGATTCCAAATGGTTATATATCACCATCAGAGATTGCCGAAGATATTGCACAGGAGAAGCTGTTTGTGCAAGGGCTCGACAAGAAGGGTCGACCTATAATTGTTGCCTTTGCAGCAAAACATTTTCAAAACAAAAATGGTGCCGATGGATTTAAACGTTATGTAGCCTTTGCTCTTGAGAAGCTATGTTCAAGGATGCCACCGGGCCAAGAAAAGTTTCTTAGCATTGCAGACATTGAAGGATGGGGATATGCAAACACTGACCTTCGTGGATACCTTAATGCTCTATCCATTTTGCAGGATTGCTACCCTGAAAGATTGGGAAAGATGTTTATTGTACACGCACCTTATTTGTTTATGAAAATTTGGAAAATGATTTACCCTTTCATTGATGACAACACCAAGAAAAAGATAGTATTTGTGGAGAACAAAAAGCTGAAATCAACATTGCTAGAAGAGATAGAAGAGAGTCAACTCCCAGATATATACGGAGGCCAAATGCCGTTAGTGCCTATCCAGGATAGCTGA | 795 | 0.4214 | MEGVVSPEEPSQRSPLDSSSKQDTTNEVLKDSTDAEITKIRLMRAFVEARDPSSKEVDDLMIRRFLRARNLDVEKGSAMFLKYLNWKRSMIPNGYISPSEIAEDIAQEKLFVQGLDKKGRPIIVAFAAKHFQNKNGADGFKRYVAFALEKLCSRMPPGQEKFLSIADIEGWGYANTDLRGYLNALSILQDCYPERLGKMFIVHAPYLFMKIWKMIYPFIDDNTKKKIVFVENKKLKSTLLEEIEESQLPDIYGGQMPLVPIQDS* | 265 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Pvu9g1660 | 264 | Gene3D | - | 4 | 263 | IPR036865 | - | |
| Pvu9g1660 | 264 | MobiDBLite | consensus disorder prediction | 1 | 30 | - | - | |
| Pvu9g1660 | 264 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 28 | 94 | IPR036273 | - | |
| Pvu9g1660 | 264 | PANTHER | OS03G0850700 PROTEIN | 18 | 264 | - | - | |
| Pvu9g1660 | 264 | PANTHER | POLYPHOSPHOINOSITIDE-BINDING PROTEIN | 18 | 264 | - | - | |
| Pvu9g1660 | 264 | SMART | CRAL_TRIO_N_2 | 58 | 83 | IPR011074 | - | |
| Pvu9g1660 | 264 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 98 | 260 | IPR001251 | - | |
| Pvu9g1660 | 264 | MobiDBLite | consensus disorder prediction | 11 | 26 | - | - | |
| Pvu9g1660 | 264 | CDD | SEC14 | 111 | 255 | IPR001251 | - | |
| Pvu9g1660 | 264 | SUPERFAMILY | CRAL/TRIO domain | 100 | 257 | IPR036865 | - | |
| Pvu9g1660 | 264 | SMART | sec14_4 | 103 | 257 | IPR001251 | - | |
| Pvu9g1660 | 264 | Pfam | CRAL/TRIO domain | 109 | 254 | IPR001251 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Pvu9g1660 | Pvu-Chr9 | 23267271 | 23269904 | Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Pvu9g1660 | 64 | 249 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 26.000 | 1.72e-11 | 61.2 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Pvu9g1660 | - | - | gmx:100797666 | 457.988 |